Integral Ad Science Holding Corp. $IAS Shares Sold by Repertoire Partners LP

Key Points

• Repertoire Partners LP has sold 82.7% of its stake in Integral Ad Science Holding Corp., reducing its ownership to 49,301 shares, valued at approximately $397,000.
• Other institutional investors, including Vanguard Group and Sunriver Management, have increased their holdings in Integral Ad Science during the same period, indicating strong institutional interest.
• Integral Ad Science reported a higher-than-expected EPS of $0.07 for the last quarter, surpassing the consensus estimate and showing encouraging revenue growth.

Repertoire Partners LP lowered its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 82.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,301 shares of the company's stock after selling 235,406 shares during the period. Integral Ad Science comprises about 0.2% of Repertoire Partners LP's investment portfolio, making the stock its 7th biggest holding. Repertoire Partners LP's holdings in Integral Ad Science were worth $397,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Integral Ad Science by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 9,090,229 shares of the company's stock valued at $73,267,000 after purchasing an additional 41,683 shares in the last quarter. Sunriver Management LLC raised its holdings in shares of Integral Ad Science by 12.0% during the 1st quarter. Sunriver Management LLC now owns 8,166,774 shares of the company's stock valued at $65,824,000 after purchasing an additional 875,740 shares in the last quarter. Corvex Management LP bought a new position in shares of Integral Ad Science during the 1st quarter valued at $21,101,000. Aberdeen Group plc raised its holdings in shares of Integral Ad Science by 12.7% during the 1st quarter. Aberdeen Group plc now owns 1,994,980 shares of the company's stock valued at $16,080,000 after purchasing an additional 224,153 shares in the last quarter. Finally, Nuveen Asset Management LLC raised its holdings in shares of Integral Ad Science by 0.8% during the 4th quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock valued at $20,050,000 after purchasing an additional 15,432 shares in the last quarter. Institutional investors and hedge funds own 95.78% of the company's stock.

Insider Activity

In other news, CEO Lisa Utzschneider sold 14,904 shares of the business's stock in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total transaction of $123,852.24. Following the transaction, the chief executive officer owned 379,316 shares in the company, valued at approximately $3,152,115.96. The trade was a 3.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders have sold 35,073 shares of company stock worth $289,641. Insiders own 2.00% of the company's stock.

Integral Ad Science Price Performance

Shares of IAS opened at $8.72 on Friday. The company has a market capitalization of $1.45 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 1.27 and a beta of 1.57. Integral Ad Science Holding Corp. has a one year low of $6.26 and a one year high of $13.62. The company's fifty day moving average price is $8.54 and its 200 day moving average price is $8.32.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The firm had revenue of $149.20 million for the quarter, compared to the consensus estimate of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Analysts Set New Price Targets

IAS has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Integral Ad Science from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Raymond James Financial cut their price target on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. Stifel Nicolaus raised their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Finally, Barclays lifted their target price on shares of Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.